Accuray (ARAY) Income from Non-Controlling Interests (2011 - 2025)
Accuray (ARAY) posted quarterly Income from Non-Controlling Interests of $439000.0 for Q2 2025, up 709.72% year-over-year from $54216.1 in Q2 2024, and down 88.53% quarter-over-quarter from $3.8 million in Q4 2024.
Accuray (ARAY) Income from Non-Controlling Interests (2011 - 2025) Analysis & Trends
Accuray's Income from Non-Controlling Interests history runs 12 years deep, the most recent figure standing at $439000.0 for Q2 2025.
- In Q2 2025, Income from Non-Controlling Interests rose 709.72% year-over-year to $439000.0; the TTM figure through Jun 2025 stood at $5.8 million (up 504.17% YoY), while the FY2025 annual figure was $439000.0, up 709.72% from the prior year.
- Income from Non-Controlling Interests for Q2 2025 stood at $439000.0, down from $3.8 million in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $3.8 million in Q4 2024, with the low at -$1.2 million in Q3 2021.
- The 5-year median for Income from Non-Controlling Interests is $431000.0 (2023), against an average of $505461.5.
- The sharpest annual moves came in 2021 and 2025: Income from Non-Controlling Interests tumbled 1114.29% in 2021, then soared 709.72% in 2025.
- Accuray's Income from Non-Controlling Interests stood at $740000.0 in 2021, then jumped by 162.97% to $1.9 million in 2022, then tumbled by 47.17% to $1.0 million in 2023, then soared by 272.47% to $3.8 million in 2024, then sank by 88.53% to $439000.0 in 2025.
- Business Quant data shows ARAY's Income from Non-Controlling Interests at $439000.0 in Q2 2025, $3.8 million in Q4 2024, and $1.6 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 900,000.00 |
| 10 | Accuray | 35.28 Mn | -4.42 Mn | 25.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 439,000.00 |
| Dec 31, 2024 | 3.83 Mn |
| Sep 30, 2024 | 1.60 Mn |
| Jun 30, 2024 | -72,000.00 |
| Dec 31, 2023 | 1.03 Mn |
| Sep 30, 2023 | -427,000.00 |
| Jun 30, 2023 | 431,000.00 |
| Dec 31, 2022 | 1.95 Mn |
| Sep 30, 2022 | -1.07 Mn |
| Jun 30, 2022 | -368,000.00 |
| Dec 31, 2021 | 740,000.00 |
| Sep 30, 2021 | -1.17 Mn |
| Jun 30, 2021 | -340,000.00 |
| Dec 31, 2020 | 1.02 Mn |
| Sep 30, 2020 | 1.09 Mn |
| Jun 30, 2020 | -28,000.00 |
| Mar 31, 2020 | -149,000.00 |
| Mar 31, 2018 | 319,000.00 |
| Dec 31, 2017 | 102,000.00 |
| Sep 30, 2017 | 22,000.00 |